Effect of PEG Surface Conformation on Anticancer Activity and Blood Circulation of Nanoemulsions Loaded with Tocotrienol-Rich Fraction of Palm Oil

被引:32
作者
Alayoubi, Alaadin [1 ]
Alqahtani, Saeed [1 ]
Kaddoumi, Amal [1 ]
Nazzal, Sami [1 ]
机构
[1] Univ Louisiana Monroe, Coll Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71201 USA
来源
AAPS JOURNAL | 2013年 / 15卷 / 04期
关键词
nanoemulsion; PEG(2000)-DSPE; PEGylation; poloxamer; tocotrienol; PLASMA-PROTEIN ADSORPTION; SOLID-LIPID-NANOPARTICLES; MAMMARY-TUMOR CELLS; CELLULAR UPTAKE; GAMMA-TOCOTRIENOL; POLY(ETHYLENE GLYCOL); OXIDE NANOPARTICLES; DRUG-DELIVERY; FAT EMULSIONS; SIZE;
D O I
10.1208/s12248-013-9525-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tocotrienol-rich fraction of palm oil, which contains the isomers of vitamin E, was shown to possess potent anticancer activity against mammary adenocarcinoma cell lines. Its clinical use, however, is limited by poor oral bioavailability and short half-life. Previously, we developed tocotrienol-rich lipid nanoemulsions for intravenous administration. The objective of this study was to investigate the effect of surface grafted polyethylene glycol (PEG) on the properties of the nanoemulsions. PEGylation was achieved by the addition of equimolar PEG groups using poloxamer or 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)2000] (PEG(2000)-DSPE). The effect of PEG surface topography on the antiproliferative activity of nanoemulsions against mammary adenocarcinoma cells, their susceptibility to protein adsorption, and its effect on blood hemolysis and circulation time was investigated. Nanoemulsions PEGylated with poloxamer or PEG(2000)-DSPE were stable under physical stress. Poloxamer nanoemulsion, however, displayed higher uptake and potency against MCF-7 tumor cells in 2D and 3D culture and increased hemolytic effect and susceptibility to IgG adsorption, which was reflected in its rapid clearance and short circulation half-life (1.7 h). Conversely, PEGylation with PEG(2000)-DSPE led to a 7-fold increase in mean residence time (12.3 h) after IV injection in rats. Reduced activity in vitro and improved circulation time suggested strong shielding of plasma proteins from the droplets. Differences between the nanoemulsions were attributed to polymer imbibitions and the differences in PEG conformation and density on the surface of the droplets.
引用
收藏
页码:1168 / 1179
页数:12
相关论文
共 64 条
  • [1] Development and validation of a reversed-phase HPLC method for the determination of γ-tocotrienol in rat and human plasma
    Abuasal, Bilal
    Thomas, Shawn
    Sylvester, Paulw.
    Kaddoumi, Amal
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2011, 25 (05) : 621 - 627
  • [2] Stability and in vitro antiproliferative activity of bioactive "Vitamin E" fortified parenteral lipid emulsions
    Alayoubi, Alaadin
    Kanthala, Shanthi
    Satyanarayanajois, Seetharama D.
    Anderson, John F.
    Sylvester, Paul W.
    Nazzal, Sami
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2013, 103 : 23 - 30
  • [3] "Vitamin E" fortified parenteral lipid emulsions: Plackett-Burman screening of primary process and composition parameters
    Alayoubi, Alaadin
    Nazzal, Mahmoud
    Sylvester, Paul W.
    Nazzal, Sami
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2013, 39 (02) : 363 - 373
  • [4] Concurrent delivery of tocotrienols and simvastatin by lipid nanoemulsions potentiates their antitumor activity against human mammary adenocarcenoma
    Alayoubi, Alaadin Y.
    Anderson, John F.
    Satyanarayanajois, Seetharama D.
    Sylvester, Paul W.
    Nazzal, Sami
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 48 (03) : 385 - 392
  • [5] Nonlinear Absorption Kinetics of Self-Emulsifying Drug Delivery Systems (SEDDS) Containing Tocotrienols as Lipophilic Molecules: In Vivo and In Vitro Studies
    Alqahtani, Saeed
    Alayoubi, Alaadin
    Nazzal, Sami
    Sylvester, Paul W.
    Kaddoumi, Amal
    [J]. AAPS JOURNAL, 2013, 15 (03): : 684 - 695
  • [6] Enhanced antiproliferative and apoptotic response to combined treatment of γ-tocotrienol with erlotinib or gefitinib in mammary tumor cells
    Bachawal, Sunitha V.
    Wali, Vikram B.
    Sylvester, Paul W.
    [J]. BMC CANCER, 2010, 10
  • [7] Doxil® - The first FDA-approved nano-drug: Lessons learned
    Barenholz, Yechezkel
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) : 117 - 134
  • [8] Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w/o emulsions incorporating aprotinin
    Bjerregaard, S
    Wulf-Andersen, L
    Stephens, RW
    Lund, LR
    Vermehren, C
    Söderberg, I
    Frokjaer, S
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 71 (01) : 87 - 98
  • [9] A NOVEL ASSAY TO DETERMINE THE HEMOLYTIC-ACTIVITY OF DRUGS INCORPORATED IN COLLOIDAL CARRIER SYSTEMS
    BOCK, TK
    MULLER, BW
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (04) : 589 - 591
  • [10] Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells
    Chithrani, BD
    Ghazani, AA
    Chan, WCW
    [J]. NANO LETTERS, 2006, 6 (04) : 662 - 668